Share on LinkedInShare on LinkedIn

ARTICLE · 17 AUGUST 2026

Wealth Management Update - August 2026

Proskauer Rose LLP
Proskauer Rose LLP
Contributor
Proskauer Rose LLP

Proskauer Rose LLP

Firm Overview Proskauer is an elite global law firm with more than 900 lawyers across key financial...

View firm profile
Explore more from Proskauer Rose LLP

The August 2026 Section 7520 rate remains at 5.20% for estate planning techniques. Treasury Decision 10051 targets CRAT abuse schemes as listed transactions requiring disclosure. New guidance addresses Trump Account contributions, charitable LLC arrangements face IRS scrutiny, and Florida introduces streamlined trustee discharge procedures.

United StatesTax

August AFRs and 7520 Rate

The August 2026 Section 7520 rate for use with estate planning techniques such as CRTs, CLTs, QPRTs and GRATs is 5.20%, which is the same as the July 2026 Section 7520 rate. The August applicable federal rate (“AFR”) for use with a sale to a defective grantor trust or intra-family loan with a note having a duration of:

  • 3 years or less (the short-term rate, compounded annually) is 4.10%, up from 4.00% in July;
  • 3 to 9 years (the mid-term rate, compounded annually) is 4.35%, unchanged from July; and
  • 9 years or more (the long-term rate, compounded annually) is 4.92%, down from 4.98% in July.

Treasury Decision 10051 (July 9, 2026)

T.D. 19951 was issued on July 9 and finalizes proposed rules established in REG-108761-22. The final regulations target specific avoidance schemes using charitable remainder annuity trusts (CRATs) by designating these schemes as listed transactions requiring disclosure and enforcing penalties for non-compliance.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from